ALPP and endometrial cancer: The First-in-Human Anti-ALPP CAR-T Cells Immunotherapy for Ovarian and Endometrial Cancer (NCT04627740) clinical trial is a single-arm, single-center, open-label study of anti-alkaline phosphatase placental (ALPP)-positive CAR-T cells [57].